Lantern Pharma Launches ZetaOmics™ — an Autonomous, Intelligent "Computational Biologist" That Brings Expert-Grade Bioinformatics, Biostatistics & R…

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced the launch of ...

Building Clinical Software For A World That Changes Faster Than Code

In environments where software influences real clinical decisions, rigor is not optional. It is the condition that makes ...
Le Lézard

Lantern Pharma Launches ZetaOmicstm ? an Autonomous, Intelligent "Computational Biologist" That Brings Expert-Grade Bioinformatics, Biostatistics & Reasoning to Every Cancer

Lantern Pharma Inc. , a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI co-scientist platform, ...
Frontiers

Harnessing Omic Technologies: Bioinformatics Innovations in Diagnosing Microbial Infectious Diseases

The rapid evolution of omic technologies such as spanning genomics, transcriptomics, and proteomics, is reshaping how we ...

Five-agent AI team could speed clinical trial design using real-world patient records

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...